V. Proost

Arrhythmogenic Cardiomyopathy

A. Wilde, V. Proost, 2020, Electrocardiography of Inherited Arrhythmias and Cardiomyopathies.

Sex-specific aspects of phospholamban cardiomyopathy: the importance and prognostic value of low-voltage ECGs.

R. D. de Boer, M. P. van den Berg, A. Wilde, 2021, Heart rhythm.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction

A. Zwinderman, R. D. de Boer, M. P. van den Berg, 2021, European heart journal.

SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades

M. P. van den Berg, A. Wilde, C. Remme, 2023, Netherlands Heart Journal.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, Lancet.

Lack of Evidence for the Role of the p.(Ser96Ala) Polymorphism in Histidine-Rich Calcium Binding Protein as a Secondary Hit in Cardiomyopathies

P. Ellinor, T. V. van Veen, A. Saguner, 2023, International journal of molecular sciences.

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

A. Zwinderman, P. A. van der Zwaag, A. Houweling, 2024, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.